Yet Another Bulletin Board

Welcome, Guest. Please Login or Register.
Sep 28th, 2024, 6:04pm

Home Home Help Help Search Search Members Members Member Map Member Map Login Login Register Register
Clusterheadaches.com Message Board « Research - CGRP inhibitors »


   Clusterheadaches.com Message Board
   New Message Board Archives
   2004 Cluster Headache Specific Posts
(Moderator: DJ)
   Research - CGRP inhibitors
« Previous topic | Next topic »
Pages: 1  Reply Reply Notify of replies Notify of replies Send Topic Send Topic Print Print
   Author  Topic: Research - CGRP inhibitors  (Read 326 times)
floridian
Guest

Email

Research - CGRP inhibitors
« on: Aug 15th, 2004, 10:45am »
Quote Quote Modify Modify Remove Remove

Very interesting article on how COX2 inhibitors reduce CGRP.  This isn't directly a study on clusters, but it could be relevant to us as many researchers believe that CGRP is a linch-pin in the cluster headache pain mechanism.  This ties in with previous threads on Vioxx/Celebrex and also with threads on diet (several plant compounds are COX2 inhibitors) and TMJ (injury increases CGRP).  
 
Quote:
J Orofac Pain. 2002 Fall;16(4):312-6.  
    Attenuation of pro-inflammatory neuropeptide levels produced by a cyclooxygenase-2 inhibitor in an animal model of chronic temporomandibular joint inflammation.
 
    Hutchins B, Patel H, Spears R.
 
    Department of Biomedical Sciences, Texas A&M University System Health Science Center, Baylor College of Dentistry, Dallas, Texas 75246, USA. bhutchins@tambcd.edu
 
    AIMS: To study the neurogenic effects of a cyclooxygenase-2 (COX-2) inhibitor, rofecoxib, in an animal model of persistent inflammation. METHODS: Arthritis was induced within the temporomandibular joint (TMJ) by placing complete Freund's adjuvant (CFA) within the superior joint space of the TMJ in adult male rats. The CFA animals were divided into 2 groups, with 1 group given the COX-2 inhibitor, rofecoxib, on days 21 through 28. Tissues were taken from experimental and control animals 4 weeks post-injection and analyzed by radioimmunoassay. The inflammatory-related neuropeptide, immunoreactive calcitonin gene-related peptide (CGRPi), was assayed from both the TMJ tissues and the trigeminal brain stem subnucleus caudalis. RESULTS: CGRPi content was significantly increased in TMJ tissues within the untreated CFA group (72%) and was found to be effectively no different between the CFA/COX-2 group and controls. Trigeminal brain stem subnucleus caudalis CGRPi levels were not different between the groups. CONCLUSION: These results suggest that use of an inhibitor selective for the inducible form of cyclooxygenase enzyme, COX-2, may significantly attenuate the neurogenic component in an inflammatory TMJ animal model.
IP Logged
Pages: 1  Reply Reply Notify of replies Notify of replies Send Topic Send Topic Print Print

« Previous topic | Next topic »


Clusterheadaches.com Message Board » Powered by YaBB 1 Gold - SP 1.3.1!
YaBB © 2000-2003. All Rights Reserved.


©1998-2010 Web Vision Enterprises All rights reserved. All information on this site is protected by international copyright laws. You may not re-distribute any information from this site without written permission from Web Vision Enterprises and the webmaster of this site. Violators will be prosecuted.
You may view our privacy policy and financial disclosure statement here

test rss